These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 23144203)

  • 21. Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine.
    Sundström M; Pelander A; Ojanperä I
    Drug Test Anal; 2015 May; 7(5):420-7. PubMed ID: 24953563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urine drug testing for social service agencies in Nova Scotia, Canada.
    Fraser AD
    J Forensic Sci; 1998 Jan; 43(1):194-6. PubMed ID: 9456542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a urine on-site drugs of abuse screening test in patients admitted to a psychiatric emergency unit.
    Bagøien G; Morken G; Zahlsen K; Aamo T; Spigset O
    J Clin Psychopharmacol; 2009 Jun; 29(3):248-54. PubMed ID: 19440078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower Cutoffs for LC-MS/MS Urine Drug Testing Indicates Better Patient Compliance.
    Krock K; Pesce A; Ritz D; Thomas R; Cua A; Rogers R; Lipnick P; Kilbourn K
    Pain Physician; 2017 Nov; 20(7):E1107-E1113. PubMed ID: 29149155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical issues associated with urine testing of substances of abuse.
    Eskridge KD; Guthrie SK
    Pharmacotherapy; 1997; 17(3):497-510. PubMed ID: 9165553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance evaluation of four on-site drug-testing devices for detection of drugs of abuse in urine.
    Peace MR; Tarnai LD; Poklis A
    J Anal Toxicol; 2000 Oct; 24(7):589-94. PubMed ID: 11043664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug screening during pregnancy: Urine dip cups measure up.
    Kroska EB; Meller EW; Doyle R; Coker JL; Knight BT; Ray-Griffith SL; Nembhard WN; Stowe ZN
    Drug Alcohol Depend; 2019 Nov; 204():107461. PubMed ID: 31521952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance evaluation of on-site oral fluid drug screening devices in normal police procedure in Germany.
    Musshoff F; Hokamp EG; Bott U; Madea B
    Forensic Sci Int; 2014 May; 238():120-4. PubMed ID: 24699311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urine drug screening: a valuable office procedure.
    Standridge JB; Adams SM; Zotos AP
    Am Fam Physician; 2010 Mar; 81(5):635-40. PubMed ID: 20187600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug testing in the workplace.
    Phan HM; Yoshizuka K; Murry DJ; Perry PJ
    Pharmacotherapy; 2012 Jul; 32(7):649-56. PubMed ID: 22605533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Benefits of Direct-to-Definitive Testing for Monitoring Compliance in Pain Management.
    Gencheva R; Petrides A; Kantartjis M; Tanasijevic M; Dahlin JL; Melanson S
    Pain Physician; 2018 Nov; 21(6):E583-E592. PubMed ID: 30508989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. False-positive interferences of common urine drug screen immunoassays: a review.
    Saitman A; Park HD; Fitzgerald RL
    J Anal Toxicol; 2014 Sep; 38(7):387-96. PubMed ID: 24986836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Bionike one-step tests for the detection of drugs of abuse in urine.
    Brown ER; Jarvie DR; Simpson D
    Ann Clin Biochem; 1997 Jan; 34 ( Pt 1)():74-80. PubMed ID: 9022891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Retrospective Analysis of Urine Drugs of Abuse Immunoassay True Positive Rates at a National Reference Laboratory.
    Johnson-Davis KL; Sadler AJ; Genzen JR
    J Anal Toxicol; 2016 Mar; 40(2):97-107. PubMed ID: 26668238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Saliva as a diagnostic matrix for drug abuse.
    Lo Muzio L; Falaschini S; Rappelli G; Bambini F; Baldoni A; Procaccini M; Cingolani M
    Int J Immunopathol Pharmacol; 2005; 18(3):567-73. PubMed ID: 16164838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the DrugCheck 9 on-site immunoassay test cup according to a standard method validation protocol.
    Taylor EH; Pizzo P
    J Anal Toxicol; 2004 Apr; 28(3):190-7. PubMed ID: 15107150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of hair analyses for drugs of abuse and comparison with self-reports and urine tests.
    Musshoff F; Driever F; Lachenmeier K; Lachenmeier DW; Banger M; Madea B
    Forensic Sci Int; 2006 Jan; 156(2-3):118-23. PubMed ID: 16410161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A tale of two drug testing technologies: GC-MS and LC-MS/MS.
    Mikel C; Pesce A; West C
    Pain Physician; 2010; 13(1):91-2. PubMed ID: 20119467
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug abuse proficiency testing.
    Guerrant GO; Hall CT
    Clin Toxicol; 1977; 10(2):209-19. PubMed ID: 852242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of psychoactive substances in truck drivers in the Nord-Pas-de-Calais region (France).
    Labat L; Fontaine B; Delzenne C; Doublet A; Marek MC; Tellier D; Tonneau M; Lhermitte M; Frimat P
    Forensic Sci Int; 2008 Jan; 174(2-3):90-4. PubMed ID: 17418990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.